Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout
Jiangxi Provincial People's Hopital
Jiangxi Provincial People's Hopital
M.D. Anderson Cancer Center
Beijing Tongren Hospital
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Baptist Health South Florida
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Emory University
Washington University School of Medicine
Massachusetts General Hospital
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Barbara Ann Karmanos Cancer Institute
University of Liverpool
Sun Yat-sen University
Universitätsklinikum Hamburg-Eppendorf
University of Colorado, Denver
Columbia University
University of Nebraska
Duke University
Huashan Hospital
OHSU Knight Cancer Institute
Herlev Hospital
Sun Yat-sen University
Trans Tasman Radiation Oncology Group
M.D. Anderson Cancer Center
University of Catania
Guangzhou Institute of Respiratory Disease
University of California, Davis
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
H. Lee Moffitt Cancer Center and Research Institute
UNICANCER
M.D. Anderson Cancer Center
Assistance Publique - HĂ´pitaux de Paris
Peking University People's Hospital
Norwegian University of Science and Technology
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
GU Research Network, LLC
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Stanford University
Stanford University